<DOC>
	<DOC>NCT02150213</DOC>
	<brief_summary>To provide medical follow-up to patients exposed to BGG492 for more than 28 days in study CBGG492A2207 (NCT 01147003) and/or CBGG492A2212 (NCT 01338805).</brief_summary>
	<brief_title>Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492</brief_title>
	<detailed_description>The purpose of the study was to provide medical follow-up to patients exposed to BGG492 for more than 28 days in study CBGG492A2207 (NCT 01147003) and/or CBGG492A2212 (NCT 01338805). Data from study CBGG492A2216 was used to support the clinical safety assessment of BGG492 regarding the observance of uterine endometrial stromal tumors and adrenal cortical adenomas at least one year after the completion of BGG492 treatment.</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Sarcoma, Endometrial Stromal</mesh_term>
	<mesh_term>Adrenocortical Adenoma</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>1. Written informed consent had to be obtained before any assessment was performed; 2. Patients had to be cooperative, willing to participate in the study assessments, and be able to report AEs (adverse events) themselves or have a caregiver who can record and report the events; 3. Total exposure to BGG492 treatment in Study BGG492A2207 and/or BGG492A2212 had to have been greater than 28 days 4. At least 1 year had to have elapsed since the patient received his or her last dose of BGG492. There were no exclusion criteria for this study. All patients meeting the inclusion criteria were eligible to participate in the followup safety assessments</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Adrenocortical Adenoma,</keyword>
	<keyword>Endometrial Stromal sarcomas</keyword>
	<keyword>BGG492</keyword>
</DOC>